Skip to main content

Advertisement

Table 1 Cancer related characteristics in the study and control groups

From: Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis

  All patients % (n = 212) Study group with neoadjuvant treatment % (n = 106) Control group without neoadjuvant treatment % (n = 106) p-value
Infiltration (pT)     0.02
 yT0 4.2 8.5 0  
 (y) T1 7.5 5.7 9.8  
 (y)T2 28.8 27.4 30.2  
 (y)T3 53.3 54.7 51.9  
 (y)T4 6.1 3.8 8.5  
Lymph node metastasis (pN)     0.61
Number of nodes examined 17.2 15.3 19.1 <0.001
 (y)N0 51.4 52.8 50.0  
 (y)N1 25.9 27.4 24.5  
 (y)N2 22.6 19.8 25.5  
UICC stage     0.31
 UICC 0 1.9 3.8 0  
 UICC I 27.4 24.5 30.2  
 UICC II 16.0 17.0 15.1  
 UICC III 31.1 31.1 31.1  
 UICC IV 23.6 23.6 23.6  
R-Category (incl. UICC IV)     0.59
 R0 76.8 79.0 74.5  
 R1 5.2 5.7 4.7  
 R2 18.0 15.2 20.8  
V-Category     <0.01
 V0 71.1 81.0 61.3  
 V1 23.7 15.2 32.1  
 V2 5.2 3.8 6.6  
L-Category     0.08
 L0 80.3 85.4 75.2  
 L1 19.7 14.6 24.8  
M-Category     1.00
 M0 77.4 77.4 77.4  
 M1 22.6 22.6 22.6  
G-Category     0.15
 G1 11.4 15.2 7.5  
 G2 72.0 66.7 77.4  
 G3 16.6 18.1 15.1  
Response to neoadjuvant therapy     
 No response   7.5   
 Poor to moderate regression   45.3   
 Good regression   39.6   
 Complete regression   7.5   
Adjuvant postoperative Radio- chemotherapy (% and patients)    52.9 (54 pts.)  
Completing Chemotherapy after surgery (% and patients)   59.4 (60)   
Localization     0.70
 Upper Rectum 4.8 3.8 5.7  
 Middle Rectum 41.9 40.4 43.4  
 Lower Rectum 53.3 55.8 50.9  
Tumorheight (cm) 5.6 5.3 5.9 0.22